Scott Barros

6.4k total citations · 2 hit papers
20 papers, 2.4k citations indexed

About

Scott Barros is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Scott Barros has authored 20 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Scott Barros's work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). Scott Barros is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). Scott Barros collaborates with scholars based in United States, Germany and Canada. Scott Barros's co-authors include Akin Akinc, Muthiah Manoharan, Martin A. Maier, Kevin Fitzgerald, Muthusamy Jayaraman, Steven M. Ansell, Sean C. Semple, Dominik Witzigmann, Jayesh A. Kulkarni and Ying K. Tam and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Scott Barros

20 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

2019 1.2k citations Akin Akinc, Martin A. Maier et al. Nature Nanotechnology profile →
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

2014 496 citations Kathryn A. Whitehead, J. Robert Dorkin et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Barros United States	14	1.8k	372	321	291	244	20	2.4k
Shintaro Fumoto Japan	20	1.1k 0.6×	287 0.8×	237 0.7×	179 0.6×	444 1.8×	86	1.5k
Tracie Delgado United States	8	660 0.4×	333 0.9×	235 0.7×	233 0.8×	125 0.5×	11	1.5k
Leaf Huang United States	25	1.2k 0.7×	743 2.0×	691 2.2×	481 1.7×	147 0.6×	45	2.2k
Jiwu Wei China	25	941 0.5×	131 0.4×	186 0.6×	475 1.6×	381 1.6×	59	1.9k
Lei Yu China	32	1.1k 0.6×	495 1.3×	663 2.1×	460 1.6×	256 1.0×	104	2.7k
Troy O. Harasym Canada	21	1.3k 0.7×	915 2.5×	483 1.5×	174 0.6×	88 0.4×	45	2.2k
Giovanna Esposito Italy	20	633 0.3×	184 0.5×	215 0.7×	129 0.4×	96 0.4×	43	1.5k
Marlene Modi United States	13	745 0.4×	324 0.9×	177 0.6×	286 1.0×	107 0.4×	18	2.3k
Hee‐Seung Bom South Korea	25	526 0.3×	222 0.6×	784 2.4×	145 0.5×	317 1.3×	126	2.6k
Vasant Jadhav United States	20	2.2k 1.2×	107 0.3×	99 0.3×	249 0.9×	287 1.2×	35	2.5k

Countries citing papers authored by Scott Barros

Since Specialization

Citations

This map shows the geographic impact of Scott Barros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Barros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Barros more than expected).

Fields of papers citing papers by Scott Barros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Barros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Barros. The network helps show where Scott Barros may publish in the future.

Co-authorship network of co-authors of Scott Barros

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Barros. A scholar is included among the top collaborators of Scott Barros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Barros. Scott Barros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crabtree, Juliet, Akinola Olumide Emmanuel, David Soto, et al.. (2024). In Vivo panCAR-Mediated Depletion of B Cells in Non-Human Primates Using a Circular (oRNA®) Anti-CD20 CAR. Blood. 144(Supplement 1). 3427–3427. 2 indexed citations

Akinc, Akin, Martin A. Maier, Muthiah Manoharan, et al.. (2019). The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nature Nanotechnology. 14(12). 1084–1087. 1160 indexed citations breakdown →

Janas, Maja M., et al.. (2016). Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro Cytotoxicity. Nucleic Acid Therapeutics. 27(1). 11–22. 35 indexed citations

Berman, Carol W., Scott Barros, Sheila M. Galloway, et al.. (2016). OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics. Nucleic Acid Therapeutics. 26(2). 73–85. 33 indexed citations

Janas, Maja M., Yongfeng Jiang, Ju Liu, et al.. (2016). Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity. Nucleic Acid Therapeutics. 26(6). 363–371. 22 indexed citations

Sehgal, Alfica, Keith Blomenkamp, Amy Simon, et al.. (2015). 279 Pre-Clinical Evaluation of ALN-AAT to Ameliorate Liver Disease Associated With Alpha-1-Antitrypsin Deficiency. Gastroenterology. 148(4). S–975. 8 indexed citations

Kumar, Varun, June Qin, Yongfeng Jiang, et al.. (2014). Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy. Molecular Therapy — Nucleic Acids. 3. e210–e210. 175 indexed citations

Whitehead, Kathryn A., J. Robert Dorkin, Arturo J. Vegas, et al.. (2014). Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nature Communications. 5(1). 4277–4277. 496 indexed citations breakdown →

Sørensen, Benny, Tim Mant, Akin Akinc, et al.. (2014). A Subcutaneously Administered RNAi Therapeutic (ALN-AT3) Targeting Antithrombin for Treatment of Hemophilia: Interim Phase 1 Study Results in Healthy Volunteers and Patients with Hemophilia a or B. Blood. 124(21). 693–693. 14 indexed citations

10.

Querbes, William, Scott Barros, Renta Hutabarat, et al.. (2013). Abstract 15574: A Subcutaneous Platform for RNAi Therapeutics Targeting ANGPTL3. Circulation. 128. 1 indexed citations

11.

Barros, Scott, Julia Hettinger, Yongfeng Jiang, et al.. (2013). Expanded Therapeutic Index Of Antithrombin Silencing and Correction Of Aptt In a Hemophilia A Mouse Model. Blood. 122(21). 3585–3585. 1 indexed citations

12.

Foster, Donald J., Scott Barros, Sarfraz Shaikh, et al.. (2012). Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo. RNA. 18(3). 557–568. 38 indexed citations

13.

Barros, Scott & Jared Gollob. (2012). Safety profile of RNAi nanomedicines. Advanced Drug Delivery Reviews. 64(15). 1730–1737. 103 indexed citations

14.

Akinc, Akin, Alfica Sehgal, Scott Barros, et al.. (2012). An RNAi Therapeutic Targeting Antithrombin Increases Thrombin Generation in Nonhuman Primates. Blood. 120(21). 3370–3370. 5 indexed citations

15.

Barros, Scott & Rory Martin. (2008). Predictive Toxicogenomics in Preclinical Discovery. Methods in molecular biology. 460. 89–112. 9 indexed citations

16.

Barros, Scott, Chutima Srimaroeng, Jennifer L. Perry, et al.. (2008). Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport. Journal of Biological Chemistry. 284(5). 2672–2679. 40 indexed citations

17.

Aslamkhan, Amy G., Deborah Thompson, Jennifer L. Perry, et al.. (2006). The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 291(6). R1773–R1780. 20 indexed citations

18.

Martin, Rory, David M. Rose, Kai Yu, & Scott Barros. (2006). Toxicogenomics Strategies for Predicting Drug Toxicity. Pharmacogenomics. 7(7). 1003–1016. 23 indexed citations

19.

Barros, Scott, Raymond W. Tennant, & Ronald E. Cannon. (2003). Molecular structure and characterization of a novel murine ABC transporter, Abca13. Gene. 307. 191–200. 18 indexed citations

20.

Hamilton, Geraldine A., et al.. (2001). Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell and Tissue Research. 306(1). 85–99. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact